Drugs / GBR 900
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02235727 | Jul 2014 → Nov 2016 | — | Glenmark Pharmaceuticals Ltd. India | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GBR 900 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02235727 ↗ |